Drugs / AR09
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02027155 Comparator | Dec 2013 → Apr 2014 | — | Arbor Pharmaceuticals, Inc. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AR09 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02027155 ↗ |
| Route | Intravenous | “single IV doses of AR09” NCT02027155 ↗ |